Arcxis Biotechnologies Gets Investment From In-Q-Tel
Pleasanton-based Arcxis Biotechnologies, which develops biomedical devices for extracting, isolating, and purifying RNA and DNA, said Thursday afternoon that the firm has scored an investment from In-Q-Tel, the venture capital arm of the CIA. According to Arcxis, the investment is part of a strategic partnership and technology development agreement with In-Q-Tel, around accelerating availability of its product line. Amount of the investment was not disclosed. Arcxis said that the invesetment was linked to the firm's earlier announced funding round, which was led by Claremont Creek Ventures, Kaiser Permanente Ventures and Alafi Capital. In-Q-Tel invests in companies that support the mission of the CIA and other U.S. intelligence agencies.
posted on Thursday, March 12, 2009 (Link to more information)
Related companies:
Arcxis
Related stories:
> Arcxis Biotechnologies Gains Series B
> Arcxis Gets $2.25M In Funding
> Microchip Biotechnologies Gains $18.1M
> Amyris Biotechnologies Gets $24.75M
> Refuge Biotechnologies Picks Up $25M
silicontap.com Home